Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$243K Sell
8,667
-4,129
-32% -$110K 0.01% 303
2025
Q4
$319K Sell
12,796
-4,673
-27% -$118K 0.01% 282
2025
Q3
$445K Sell
17,469
-2,499
-13% -$61.7K 0.02% 259
2025
Q2
$484K Buy
19,968
+1,390
+7% +$32.4K 0.02% 275
2025
Q1
$471K Sell
18,578
-3,302
-15% -$86.4K 0.02% 273
2024
Q4
$580K Sell
21,880
-9,000
-29% -$244K 0.04% 195
2024
Q3
$894K Sell
30,880
-6,045
-16% -$176K 0.06% 153
2024
Q2
$1.03M Sell
36,925
-4,059
-10% -$112K 0.08% 140
2024
Q1
$1.14M Sell
40,984
-14,932
-27% -$414K 0.09% 129
2023
Q4
$1.61M Sell
55,916
-23,943
-30% -$724K 0.14% 113
2023
Q3
$2.65M Sell
79,859
-2,255
-3% -$79.7K 0.25% 88
2023
Q2
$3.01M Sell
82,114
-22,892
-22% -$891K 0.27% 87
2023
Q1
$4.28M Sell
105,006
-51,256
-33% -$2.21M 0.4% 67
2022
Q4
$8.01M Sell
156,262
-6,666
-4% -$320K 0.74% 42
2022
Q3
$7.13M Buy
162,928
+2,207
+1% +$107K 0.71% 43
2022
Q2
$8.43M Sell
160,721
-7,098
-4% -$362K 0.79% 41
2022
Q1
$8.69M Sell
167,819
-18,931
-10% -$982K 0.69% 46
2021
Q4
$11M Sell
186,750
-8,920
-5% -$442K 0.86% 35
2021
Q3
$8.41M Sell
195,670
-881
-0.4% -$39K 0.71% 46
2021
Q2
$7.7M Sell
196,551
-3,010
-2% -$117K 0.66% 47
2021
Q1
$7.23M Sell
199,561
-8,613
-4% -$306K 0.68% 44
2020
Q4
$7.66M Sell
208,174
-29,758
-13% -$1.09M 0.75% 41
2020
Q3
$8.29M Sell
237,932
-2,383
-1% -$83.5K 0.86% 37
2020
Q2
$7.45M Buy
240,315
+6,955
+3% +$236K 0.91% 33
2020
Q1
$7.22M Buy
233,360
+145,008
+164% +$4.94M 1.07% 29
2019
Q4
$8.07M Sell
88,352
-137,307
-61% -$4.89M 0.93% 32
2019
Q3
$7.69M Sell
225,659
-11,951
-5% -$435K 0.96% 32
2019
Q2
$9.77M Sell
237,610
-36,076
-13% -$1.43M 1.12% 27
2019
Q1
$11M Sell
273,686
-2,891
-1% -$116K 1.13% 28
2018
Q4
$11.5M Buy
276,577
+4,293
+2% +$178K 1.32% 18
2018
Q3
$11.4M Buy
272,284
+7,815
+3% +$301K 1.17% 24
2018
Q2
$9.1M Sell
264,469
-23
-0% -$786 1.02% 31
2018
Q1
$8.9M Buy
264,492
+4,329
+2% +$149K 1.02% 30
2017
Q4
$8.94M Buy
260,163
+15,908
+7% +$542K 0.97% 34
2017
Q3
$8.27K Buy
244,255
+2,853
+1% +$91.7K 0.93% 31
2017
Q2
$7.69M Sell
241,402
-10,960
-4% -$346K 0.99% 36
2017
Q1
$8.19M Buy
252,362
+23,842
+10% +$752K 1.07% 25
2016
Q4
$7.04M Sell
228,520
-2,694
-1% -$82.2K 1.01% 34
2016
Q3
$7.43M Buy
231,214
+6,900
+3% +$231K 1.13% 28
2016
Q2
$7.49M Sell
224,314
-6,237
-3% -$199K 1.12% 30
2016
Q1
$6.48M Buy
230,551
+1,220
+0.5% +$34.8K 1.01% 34
2015
Q4
$7.02M Buy
229,331
+5,013
+2% +$158K 1.1% 29
2015
Q3
$6.68M Sell
224,318
-20,709
-8% -$664K 1.02% 32
2015
Q2
$7.79M Buy
245,027
+16,697
+7% +$544K 1.09% 29
2015
Q1
$7.54M Buy
228,330
+18,493
+9% +$588K 1.07% 27
2014
Q4
$6.2M Buy
209,837
+36,253
+21% +$1.04M 0.97% 36
2014
Q3
$4.87M Buy
173,584
+14,279
+9% +$401K 0.74% 47
2014
Q2
$4.49M Buy
159,305
+24,294
+18% +$693K 0.74% 52
2014
Q1
$4.12M Buy
135,011
+9,613
+8% +$287K 0.66% 57
2013
Q4
$3.64M Sell
125,398
-215
-0.2% -$6.26K 0.6% 61
2013
Q3
$3.42M Buy
125,613
+5,825
+5% +$158K 0.64% 58
2013
Q2
$3.18M Buy
+119,788
New +$3.31M 0.68% 56

Other funds holding PFE

SouthState Corp's PFE Position: Q1 2026 in Review

SouthState Corp reduced its Pfizer (PFE) stake by 32% in Q1 2026, selling an estimated $110K and leaving 8,667 shares worth $243K. The position accounts for 0.01% of the portfolio, ranked #303.

SouthState Corp first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.5M in Q4 2018. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • SouthState Corp held 8,667 shares of Pfizer worth $243K as of Q1 2026.
  • SouthState Corp sold 4,129 Pfizer shares in Q1 2026, an estimated $110K.
  • Pfizer made up 0.01% of SouthState Corp's portfolio in Q1 2026, its #303 holding.
  • SouthState Corp first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • SouthState Corp's Pfizer position peaked at $11.5M in Q4 2018.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on SouthState Corp's 13F filing for Q1 2026, filed 5 May 2026.